The dual BCL-2 and BCL-XL inhibitor AZD4320 acts on-target and synergizes with MCL-1 inhibition in B-cell precursor ALL

Blood Adv. 2024 Dec 10;8(23):6035-6042. doi: 10.1182/bloodadvances.2024013194.

Authors

Maren Christiane Wichert¹, Colin Fortner^{1

2}, Alexandra Niedermayer^{1

2}, Johanna Bender^{1

2}, Stefanie Enzenmüller¹, Klaus-Michael Debatin¹, Lüder Hinrich Meyer¹, Felix Seyfried¹

Affiliations

¹ Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany.
² International Graduate School in Molecular Medicine, Ulm University, Ulm, Germany.

No abstract available